Hepatitis C therapy with long term remission after renal transplantation.

摘要: Hepatitis C virus infection (HCV) is common in patients with end-stage renal disease (ESRD) and long observation periods have shown the detrimental effect of HCV on patient graft survival after transplantation. At present, interferon most important agent for treatment hepatitis ESRD; however, limited information exists concerning long-term response who undergo transplantation successful antiviral therapy. We describe evolution a dialysis was successfully treated alpha then underwent He received aggressive immunosuppression during induction phase allograft rejection; regular screening showed complete absence biochemical virological relapse over 6-year post-transplantation period. conclude that can offer excellent selected C. Alternative strategies newer agents are currently under active investigation.